Business Segments · Segment assets
Life Sciences Solutions — Segment assets
Thermo Fisher Scientific Life Sciences Solutions — Segment assets increased by 1.3% to $3.49B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.6%, from $3.02B to $3.49B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2013
Last reportedQ1 2026May 1, 2026
Rolls up toTotal Assets
How to read this metric
An increase suggests capital expansion or investment in segment-specific infrastructure, while a decrease may indicate asset divestiture or improved capital efficiency.
Detailed definition
This metric represents the total book value of assets specifically allocated to the Life Sciences Solutions operating se...
Peer comparison
Comparable to segment-specific asset bases reported by diversified life science and biotechnology tool providers.
Metric ID:
tmo_segment_life_sciences_solutions_segment_assetsHistorical Data
9 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $22.75B | $21.85B | $3.19B | $3.21B | $2.98B | $3.02B | $3.55B | $3.45B | $3.49B |
| QoQ Change | — | -4.0% | -85.4% | +0.8% | -7.1% | +1.2% | +17.7% | -3.0% | +1.3% |
| YoY Change | — | -4.0% | -85.4% | — | -6.4% | — | +10.6% | +15.6% | +15.6% |
Range$2.98B – $22.75B
CAGR-60.8%
Avg YoY Growth-9.0%
Median YoY Growth+3.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's life sciences solutions — segment assets?
- Thermo Fisher Scientific (TMO) reported life sciences solutions — segment assets of $3.49B in Q1 2026.
- How has Thermo Fisher Scientific's life sciences solutions — segment assets changed year-over-year?
- Thermo Fisher Scientific's life sciences solutions — segment assets increased by 15.6% year-over-year, from $3.02B to $3.49B.
- What does life sciences solutions — segment assets mean?
- The total value of all assets dedicated to the Life Sciences Solutions business segment.